InterventionsHuman trial259 adults26 weeksNon-randomised trialMulticentreRegistered NCT06283641

Liraglutide in Adults With Obesity: A Multicentre, Single-Arm, Post-Marketing Surveillance Study in Taiwan

Graphical abstract from Endocrinology, Diabetes & Metabolism — Graphical abstractTu et al.

Endocrinology, Diabetes & Metabolism

The paper

Shih‐Te Tu, Chiao-Fan Chiu, Chu‐Kuang Chou,

Hai‐Hua Chuang, Hueng-Chuen Fan, Wen‐Ching Ko, Chun‐Ying Lee, Wen‐Yuan Lin, Yen‐Jen Sung, Thing‐Fong Tzeng, Weu Wang, Hsiang-fan Wu, Chun‐Yan Yeung, Bill Chen, Chet Joe Sim,

Kuo‐Chin Huang

Changhua Christian Hospital · National Taiwan University

Endocrinology, Diabetes & Metabolism · 1 Sep 2026

doi.org/10.1002/edm2.70333 PubMed 42762462

Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026